KWALITY PHARMACEUTICALS L Share Price

KWALITY PHARMACEUTICALS L Share Price

₹ 3,525.00

-₹40.50 (-1.14%)
1D
Last updated 13 Oct, 2026, 15:29 IST

KWALITY PHARMACEUTICALS L Share Price Today

As of 14 Oct 2026, KWALITY PHARMACEUTICALS L share price is ₹3,525.00. The stock opened at ₹3,583.30, compared to its previous close of ₹3,565.50. During today's trading session, KWALITY PHARMACEUTICALS L share price moved in the range of ₹3,429.30 to ₹3,597.80, with an average price of ₹3,513.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,561.00 and a high of ₹3,949.00. On the performance front, KWALITY PHARMACEUTICALS L share price has increased by 117.90% over the last six months and is up 117.90% on a year-on-year basis.

₹3,429.30
1.14% down today
₹3,597.80
1D LOW
1D HIGH

KWALITY PHARMACEUTICALS L Returns Calculator

Volume
25,874
Average traded price
₹3,484.21
Last traded time
03:29:45 13 Oct
Last traded quantity
1
Circuit
L
H
₹2,852.40
₹4,278.60
52-week
L
H
₹1,561.00
₹3,949.00
Mkt Cap Cr
3,696.31
P/E
45.61
P/B
11.17
ROA
13.69%
ROE
20.31%
ROCE
21.46%
Quick Ratio
1.45
EV/EBITDA
27.85
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Kwality Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Kwality Pharma appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Kwality Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About KWALITY PHARMACEUTICALS L

KWALITY PHARMACEUTICALS L Share Price
ISIN
INE552U01010
Sector Market Cap
₹ 3,696.31 Cr

Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.

KWALITY PHARMACEUTICALS L Financial Highlights

  • Revenue: KWALITY PHARMACEUTICALS L reported revenue of ₹505.94 crore in FY26 vs ₹372.12 crore in FY25. It showed an increase of 35.96% on a yearly basis.
  • Operating Profit: KWALITY PHARMACEUTICALS L reported an operating profit of ₹89.49 crore in FY26 vs ₹54.14 crore in FY25. It showed an increase of 65.29% on a year-on-year basis.
  • Net Profit: KWALITY PHARMACEUTICALS L reported a net profit of ₹67.35 crore in FY26 vs ₹39.80 crore in FY25. It showed an increase of 69.22% on a yearly basis.

KWALITY PHARMACEUTICALS L Quarterly Result Highlights

  • KWALITY PHARMACEUTICALS L reported revenue of ₹162.97 crore in Jun 2026, compared with ₹158.17 crore in Mar 2026, representing an increase of 3.03% on a quarter-on-quarter (QoQ) basis.
  • KWALITY PHARMACEUTICALS L reported an operating profit of ₹33.99 crore in Jun 2026, compared with ₹31.67 crore in Mar 2026, representing an increase of 7.33% on a quarter-on-quarter (QoQ) basis.
  • KWALITY PHARMACEUTICALS L reported a profit of ₹25.62 crore in Jun 2026, compared with ₹25.31 crore in Mar 2026, reflecting an increase of 1.22% on a QoQ basis.
  • The earnings per share (EPS) of KWALITY PHARMACEUTICALS L stood at ₹64.90 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
54.86%
FII
3.13%
Other DII
0.56%
Retail and other
41.44%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.50%
Mar 20262.79%
Jun 20263.13%
1 day
-0.90%
1 week
-5.65%
1 month
-3.02%
1 year
+117.90%
3 years
+117.90%
5 years
+117.90%
Day
Open / Close
Change %
13 Oct 26
₹3,583.30 / ₹3,525.00
-1.14%
12 Oct 26
₹3,599.00 / ₹3,565.50
+0.03%
09 Oct 26
₹3,539.00 / ₹3,564.30
+0.88%
08 Oct 26
₹3,680.00 / ₹3,533.30
-4.02%
Show more

KWALITY PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹503.08₹370.20₹307.17₹251.03
Other Income₹2.86₹1.92₹1.83₹2.94
Total Revenue₹505.94₹372.12₹309.00₹253.97
Total Expenses₹415.62₹317.98₹270.80₹211.87
Profit Before Tax₹89.49₹54.14₹31.10₹25.57
Tax₹22.15₹14.34₹7.48₹6.29
Profit After Tax₹67.35₹39.80₹23.62₹19.28
EPS - Basic₹64.90₹38.36₹22.76₹18.16
EPS - Diluted₹64.90₹38.36₹22.76₹18.16

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹89.49₹54.14₹31.10₹25.57
Income before WC changes₹120.76₹82.14₹67.72₹46.52
Change in Assets-₹133.18-₹31.33-₹41.49₹14.55
Change in Liabilities₹50.25₹17.69₹18.06-₹13.54
Change in WC-₹82.93-₹13.64-₹23.44₹1.01
Cash flow from Operations₹17.06₹52.72₹42.98₹41.38
Cash flow from Investing-₹34.91-₹28.52-₹26.40-₹48.44
Cash flow from Financing₹7.04-₹14.44-₹17.40₹0.99
Total Cash Flow-₹10.81₹9.76-₹0.81-₹6.07
Cash (Start of the year)₹12.02₹2.26₹3.07₹9.13
Cash (End of the year)₹1.21₹12.02₹2.26₹3.07

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹186.53₹163.49₹151.52₹146.43
Current Assets₹405.68₹283.78₹242.69₹207.20
Total Assets₹592.21₹447.27₹394.21₹353.63
Current Liabilities₹225.52₹169.51₹151.85₹125.95
Net Current Asset₹180.16₹114.27₹90.84₹81.25
Non-Current Liabilities₹36.77₹15.37₹19.78₹28.62
Equity Capital₹329.92₹262.40₹222.58₹199.07
Total Equity & Liabilities₹592.21₹447.27₹394.21₹353.63

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹503.06₹370.20₹307.17₹250.99
Other Income₹2.86₹1.92₹1.83₹2.94
Total Revenue₹505.92₹372.12₹309.00₹253.94
Total Expenses₹415.60₹317.89₹270.44₹211.65
Profit Before Tax₹89.49₹54.23₹31.47₹25.76
Tax₹22.15₹14.34₹7.48₹6.29
Profit After Tax₹67.35₹39.89₹23.98₹19.47
EPS - Basic₹64.90₹38.44₹23.11₹18.45
EPS - Diluted₹64.90₹38.44₹23.11₹18.45

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹89.49₹54.23₹31.47₹25.76
Income before WC changes₹120.74₹82.20₹68.08₹46.67
Change in Assets-₹132.76-₹31.33-₹41.49₹14.54
Change in Liabilities₹49.78₹17.69₹18.07-₹12.86
Change in WC-₹82.98-₹13.64-₹23.43₹1.67
Cash flow from Operations₹17.00₹52.77₹43.35₹42.19
Cash flow from Investing-₹34.91-₹28.13-₹26.40-₹48.44
Cash flow from Financing₹7.04-₹14.44-₹17.40₹0.99
Total Cash Flow-₹10.87₹10.20-₹0.45-₹5.26
Cash (Start of the year)₹11.55₹1.35₹1.80₹7.06
Cash (End of the year)₹0.68₹11.55₹1.35₹1.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹188.87₹165.82₹154.19₹149.06
Current Assets₹406.79₹284.90₹243.38₹207.52
Total Assets₹595.66₹450.72₹397.57₹356.58
Current Liabilities₹225.52₹169.51₹151.85₹125.94
Net Current Asset₹181.27₹115.40₹91.53₹81.58
Non-Current Liabilities₹36.77₹15.37₹19.78₹28.62
Equity Capital₹333.37₹265.84₹225.95₹202.03
Total Equity & Liabilities₹595.66₹450.72₹397.57₹356.58
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.4
Neutral
ATR (14)
145.59
Neutral
STOCH(9,6)
26.99
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
18.68
Bullish
UO(9)
49.68
Neutral
ROC(12)
-3.22
Bearish
WillR(14)
-76.7
Neutral
Period
Simple value
Exponential vaue
5D
3617.86
3591.21
10D
3614.13
3605.6
20D
3606.56
3578.54
50D
3387.66
3395.67
100D
2940.89
3543.75
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
KWALITY PHARMACEUTICALS L Share Price
KWALITY PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

KWALITY PHARMACEUTICALS L Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.